Skip to main content
HR 3162 119th Congress House Health

Affordable and Safe Prescription Drug Importation Act of 2025

Introduced: May 1, 2025 Introduced by: Schakowsky, Janice D. Democratic · Illinois See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 1, 2025
Referred to the House Committee on Energy and Commerce.
May 1, 2025
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Affordable and Safe Prescription Drug Importation Act of 2025

This bill expands the categories of prescription drugs that may be imported into the United States and the countries from which such drugs may be imported.

Current law allows the Department of Health and Human Services (HHS) to authorize importation of certain eligible prescription drugs from Canada if HHS certifies that doing so would pose no additional risk to public health and safety, among other requirements. HHS long declined to make the requisite certification, citing safety concerns (e.g., contamination, counterfeiting), but ultimately made the certification in 2020 and has since approved one state plan to import drugs.

The bill removes the certification requirement and requires HHS to issue regulations that permit importation of qualifying prescription drugs from the United Kingdom, Switzerland, and member states of the European Union, in addition to Canada. After one year, if HHS determines that importation of drugs from these countries has been conducted safely, HHS may authorize importation from other countries that meet certain requirements.

The bill also expands the types of prescription drugs eligible for importation to include, for example, biologics such as insulin.

Further, the bill allows individuals to use an eligible licensed foreign pharmacy to fill a U.S.-issued prescription for a qualifying drug for personal use. Currently, an individual seeking to import a prescription drug generally must acquire a waiver from HHS.

Finally, the bill imposes criminal penalties for websites that sell counterfeit drugs or dispense drugs without a required prescription.

What's happening now May 1, 2025

Referred to the House Committee on Energy and Commerce.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 6

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

 Cosponsors 5
All 5 Democratic 5
D
Cohen, Steve
Tennessee · May 1, 2025
 D
Doggett, Lloyd
Texas · May 1, 2025
 D
Omar, Ilhan
Minnesota · May 1, 2025
 D
Pingree, Chellie
Maine · May 1, 2025
 D
Pocan, Mark
Wisconsin · May 1, 2025
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 3162: Affordable and Safe Prescription Drug Importation Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-3162/
MLA
"H.R. 3162: Affordable and Safe Prescription Drug Importation Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-3162/.
Bluebook (legal)
H.R. 3162, 119th Cong. (2026), https://openamerica.io/bill/119-HR-3162/.
Markdown link
[H.R. 3162: Affordable and Safe Prescription Drug Importation Act of 2025](https://openamerica.io/bill/119-HR-3162/)
Report a problem